HuGE Literature Finder
Records 1-30
|
Identification of CDKN2A variants in breast cancer patients in Pakistan.
Genes & genetic systems 2019 Jun . Khan Ranjha, Aftab Ayesha, Tabassum Sobia, Hussain Hafiz Muhammad Jafar, Hameed Abdul, Mahmood Humera, Munir Faiza, Bukhari Ihtish |
|
Genetic polymorphisms of diabetes-related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast Cancer Study Project.
Molecular carcinogenesis 2019 03 58 (3): 436-446. Parada Humberto, Cleveland Rebecca J, North Kari E, Stevens June, Teitelbaum Susan L, Neugut Alfred I, Santella Regina M, Martinez Maria E, Gammon Marilie |
|
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
JAMA oncology 2018 Aug . Lu Hsiao-Mei, Li Shuwei, Black Mary Helen, Lee Shela, Hoiness Robert, Wu Sitao, Mu Wenbo, Huether Robert, Chen Jefferey, Sridhar Srijani, Tian Yuan, McFarland Rachel, Dolinsky Jill, Tippin Davis Brigette, Mexal Sharon, Dunlop Charles, Elliott Aar |
|
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
|
A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.
Journal of clinical laboratory analysis 2017 Mar . ShahidSales Soodabeh, Mehramiz Mehraneh, Ghasemi Faezeh, Aledavood Amir, Shamsi Mehri, Hassanian Seyed Mahdi, Ghayour-Mobarhan Majid, Avan Am |
|
Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Sep . Geurts-Giele Willemina R R, van Verschuer Victorien M T, van Deurzen Carolien H M, van Diest Paul J, Pedrosa Rute M S M, Collée J Margriet, Koppert Linetta B, Seynaeve Caroline, Dinjens Winand N |
|
Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.
Experimental and molecular pathology 2016 Apr 100 (3): 421-425. Muller Kristen E, Marotti Jonathan D, de Abreu Francine B, Peterson Jason D, Miller Todd W, Chamberlin Mary D, Tsongalis Gregory J, Tafe Laura |
|
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2015 Aug 17 (8): 630-8. Maxwell Kara N, Wubbenhorst Bradley, D'Andrea Kurt, Garman Bradley, Long Jessica M, Powers Jacquelyn, Rathbun Katherine, Stopfer Jill E, Zhu Jiajun, Bradbury Angela R, Simon Michael S, DeMichele Angela, Domchek Susan M, Nathanson Katherine |
|
Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.
Journal of the American Academy of Dermatology 2014 Nov 71 (5): 888-95. Potrony Miriam, Puig-Butillé Joan Anton, Aguilera Paula, Badenas Celia, Carrera Cristina, Malvehy Josep, Puig Susa |
|
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Jul 32 (19): 2001-9. Kurian Allison W, Hare Emily E, Mills Meredith A, Kingham Kerry E, McPherson Lisa, Whittemore Alice S, McGuire Valerie, Ladabaum Uri, Kobayashi Yuya, Lincoln Stephen E, Cargill Michele, Ford James |
|
Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2014 Jun 68 (5): 521-6. Stankovic Tijana, Milinkovic Vedrana, Bankovic Jasna, Dinic Jelena, Tanic Nasta, Dramicanin Tatjana, Tanic Niko |
|
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms.
Oncotarget 2014 May 5 (9): 2349-54. Wheler Jennifer J, Parker Barbara A, Lee Jack J, Atkins Johnique T, Janku Filip, Tsimberidou Apostolia M, Zinner Ralph, Subbiah Vivek, Fu Siqing, Schwab Richard, Moulder Stacy, Valero Vicente, Schwaederle Maria, Yelensky Roman, Miller Vincent A, Stephens M Philip J, Meric-Bernstam Funda, Kurzrock Razel |
|
Breast cancer subtypes and previously established genetic risk factors: a bayesian approach.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014 Jan 23 (1): 84-97. O'Brien Katie M, Cole Stephen R, Engel Lawrence S, Bensen Jeannette T, Poole Charles, Herring Amy H, Millikan Robert |
|
Evaluating genome-wide association study-identified breast cancer risk variants in African-American women.
PloS one 2013 8 (4): e58350. Long Jirong, Zhang Ben, Signorello Lisa B, Cai Qiuyin, Deming-Halverson Sandra, Shrubsole Martha J, Sanderson Maureen, Dennis Joe, Michailidou Kyriaki, Michailiou Kyriaki, Easton Douglas F, Shu Xiao-Ou, Blot William J, Zheng W |
|
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
PLoS genetics 2013 9 (3): e1003173. Gaudet Mia M, Kuchenbaecker Karoline B, Vijai Joseph, Klein Robert J, Kirchhoff Tomas, McGuffog Lesley, Barrowdale Daniel, Dunning Alison M, Lee Andrew, Dennis Joe, Healey Sue, Dicks Ed, Soucy Penny, Sinilnikova Olga M, Pankratz Vernon S, Wang Xianshu, Eldridge Ronald C, Tessier Daniel C, Vincent Daniel, Bacot Francois, Hogervorst Frans B L, Peock Susan, Stoppa-Lyonnet Dominique, , Peterlongo Paolo, Schmutzler Rita K, Nathanson Katherine L, Piedmonte Marion, Singer Christian F, Thomassen Mads, , Hansen Thomas v O, Neuhausen Susan L, Blanco Ignacio, Greene Mark H, Garber Judith, Weitzel Jeffrey N, Andrulis Irene L, Goldgar David E, D'Andrea Emma, Caldes Trinidad, Nevanlinna Heli, Osorio Ana, van Rensburg Elizabeth J, Arason Adalgeir, Rennert Gad, van den Ouweland Ans M W, van der Hout Annemarie H, Kets Carolien M, Aalfs Cora M, Wijnen Juul T, Ausems Margreet G E M, , , Frost Debra, Ellis Steve, Fineberg Elena, Platte Radka, Evans D Gareth, Jacobs Chris, Adlard Julian, Tischkowitz Marc, Porteous Mary E, Damiola Francesca, , Golmard Lisa, Barjhoux Laure, Longy Michel, Belotti Muriel, Ferrer Sandra Fert, Mazoyer Sylvie, Spurdle Amanda B, Manoukian Siranoush, Barile Monica, Genuardi Maurizio, Arnold Norbert, Meindl Alfons, Sutter Christian, Wappenschmidt Barbara, Domchek Susan M, Pfeiler Georg, Friedman Eitan, Jensen Uffe Birk, Robson Mark, Shah Sohela, Lazaro Conxi, Mai Phuong L, Benitez Javier, Southey Melissa C, Schmidt Marjanka K, Fasching Peter A, Peto Julian, Humphreys Manjeet K, Wang Qin, Michailidou Kyriaki, Sawyer Elinor J, Burwinkel Barbara, Guénel Pascal, Bojesen Stig E, Milne Roger L, Brenner Hermann, Lochmann Magdalena, , Aittomäki Kristiina, Dörk Thilo, Margolin Sara, Mannermaa Arto, Lambrechts Diether, Chang-Claude Jenny, Radice Paolo, Giles Graham G, Haiman Christopher A, Winqvist Robert, Devillee Peter, García-Closas Montserrat, Schoof Nils, Hooning Maartje J, Cox Angela, Pharoah Paul D P, Jakubowska Anna, Orr Nick, González-Neira Anna, Pita Guillermo, Alonso M Rosario, Hall Per, Couch Fergus J, Simard Jacques, Altshuler David, Easton Douglas F, Chenevix-Trench Georgia, Antoniou Antonis C, Offit Kenne |
|
Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.
Breast cancer research and treatment 2011 Sep 129 (2): 557-63. Bernholtz Shiri, Laitman Yael, Kaufman Bella, Paluch Shimon Shani, Friedman Eit |
|
Can a phenotype for recessive inheritance in breast cancer be defined?
Familial cancer 2010 Dec 9 (4): 525-30. Ellberg Carolina, Jönsson Göran, Olsson Håk |
|
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.
Familial cancer 2010 Dec 9 (4): 663-7. Buecher B, Gauthier-Villars M, Desjardins L, Lumbroso-Le Rouic L, Levy C, De Pauw A, Bombled J, Tirapo C, Houdayer C, Bressac-de Paillerets B, Stoppa-Lyonnet |
|
Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
Melanoma research 2009 Aug 19 (4): 211-4. Nagore Eduardo, Montoro Alegria, García-Casado Zaida, Botella-Estrada Rafael, Insa Amelia, Lluch Ana, López-Guerrero José A, Guillén Carl |
|
CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Mar 18 (3): 901-14. Vasilatos Shauna N, Broadwater Gloria, Barry William T, Baker Joseph C, Lem Siya, Dietze Eric C, Bean Gregory R, Bryson Andrew D, Pilie Patrick G, Goldenberg Vanessa, Skaar David, Paisie Carolyn, Torres-Hernandez Alejandro, Grant Tracey L, Wilke Lee G, Ibarra-Drendall Catherine, Ostrander Julie H, D'Amato Nicholas C, Zalles Carola, Jirtle Randy, Weaver Valerie M, Seewaldt Victoria |
|
Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology.
Breast cancer research and treatment 2009 Mar 114 (1): 121-6. Lubi?ski Jan, Korze? Marcin, Górski Bohdan, Cybulski Cezary, Debniak Tadeusz, Jakubowska Anna, Jaworska Katarzyna, Woko?orczyk Dominika, Medrek Krzysztof, Matyjasik Joanna, Huzarski Tomasz, Byrski Tomasz, Gronwald Jacek, Masoj? Bart?omiej, Lener Marcin, Szyma?ska Anna, Szyma?ska-Pasternak Jolanta, Serrano-Fernàndez Pablo, Piegat Andrzej, Uci?ski Rafa?, Domaga?a Pawe?, Domaga?a Wenancjusz, Chosia Maria, K?adny Józef, Górecka Barbara, Narod Steven, Scott Rodn |
|
Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Jan 18 (1): 255-9. Mavaddat Nasim, Dunning Alison M, Ponder Bruce A J, Easton Douglas F, Pharoah Paul |
|
Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2008 Oct 17 (5): 389-91. Debniak Tadeusz, van de Wetering Thierry, Scott Rodney, Nagay Leszek, Cybulski Cezary, Górski Bohdan, Jakubowska Anna, Gronwald Jacek, Masoj? Bart?omiej, Huzarski Tomasz, Byrski Tomasz, Nej-Wo?osiak Katarzyna, K?adny Józef, Maleszka Romuald, Lubinski J |
|
Consortium analysis of 7 candidate SNPs for ovarian cancer.
International journal of cancer. Journal international du cancer 2008 Jul 123 (2): 380-8. Ramus Susan J, Vierkant Robert A, Johnatty Sharon E, Pike Malcolm C, Van Den Berg David J, Wu Anna H, Pearce Celeste Leigh, Menon Usha, Gentry-Maharaj Aleksandra, Gayther Simon A, Dicioccio Richard A, McGuire Valerie, Whittemore Alice S, Song Honglin, Easton Douglas F, Pharoah Paul D P, Garcia-Closas Montserrat, Chanock Stephen, Lissowska Jolanta, Brinton Louise, Terry Kathryn L, Cramer Daniel W, Tworoger Shelley S, Hankinson Susan E, Berchuck Andrew, Moorman Patricia G, Schildkraut Joellen M, Cunningham Julie M, Liebow Mark, Kjaer Susanne Krüger, Hogdall Estrid, Hogdall Claus, Blaakaer Jan, Ness Roberta B, Moysich Kirsten B, Edwards Robert P, Carney Michael E, Lurie Galina, Goodman Marc T, Wang-Gohrke Shan, Kropp Silke, Chang-Claude Jenny, , , Webb Penelope M, Chen Xiaoqing, Beesley Jonathan, Chenevix-Trench Georgia, Goode Ellen L, |
|
Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
Carcinogenesis 2008 Feb 29 (2): 333-41. Driver Kristy E, Song Honglin, Lesueur Fabienne, Ahmed Shahana, Barbosa-Morais Nuno L, Tyrer Jonathan P, Ponder Bruce A J, Easton Douglas F, Pharoah Paul D P, Dunning Alison M, |
|
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
PloS one 2008 3 (8): e3062. Chrisanthar Ranjan, Knappskog Stian, Løkkevik Erik, Anker Gun, Østenstad Bjørn, Lundgren Steinar, Berge Elisabet O, Risberg Terje, Mjaaland Ingvil, Maehle Lovise, Engebretsen Lars Fredrik, Lillehaug Johan Richard, Lønning Per Eyste |
|
Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.
Breast cancer research : BCR 2008 10 (3): R47. Azzato Elizabeth M, Driver Kristy E, Lesueur Fabienne, Shah Mitul, Greenberg David, Easton Douglas F, Teschendorff Andrew E, Caldas Carlos, Caporaso Neil E, Pharoah Paul D |
|
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Familial cancer 2007 6 (4): 453-61. Monnerat Christian, Chompret Agnès, Kannengiesser Caroline, Avril Marie-Françoise, Janin Nicolas, Spatz Alain, Guinebretière Jean-Marc, Marian Catalin, Barrois Michel, Boitier Françoise, Lenoir Gilbert M, Bressac-de Paillerets Brigit |
|
MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk.
International journal of cancer. Journal international du cancer 2006 Dec 119 (11): 2597-602. Debniak Tadeusz, Scott Rodney, Masojc Bart?omiej, Serrano-Fernández Pablo, Huzarski Tomasz, Byrski Tomasz, Debniak Bogus?aw, Górski Bohdan, Cybulski Cezary, Medrek Krzysztof, Kurzawski Grzegorz, van de Wetering Thierry, Maleszka Romuald, K?adny Józef, Lubinski J |
|
A common variant of CDKN2A (p16) predisposes to breast cancer.
Journal of medical genetics 2005 Oct 42 (10): 763-5. Debniak T, Górski B, Huzarski T, Byrski T, Cybulski C, Mackiewicz A, Gozdecka-Grodecka S, Gronwald J, Kowalska E, Haus O, Grzybowska E, Stawicka M, Swiec M, Urba?ski K, Niepsuj S, Wa?ko B, Gó?d? S, Wandzel P, Szczylik C, Surdyka D, Rozmiarek A, Zambrano O, Posmyk M, Narod S A, Lubinski |
|
Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer.
International journal of cancer. Journal international du cancer 2004 Jul 110 (4): 558-62. Debniak Tadeusz, Górski Bohdan, Scott Rodney J, Cybulski Cezary, Medrek Krzysztof, Zowocka Elzbieta, Kurzawski Grzegorz, Debniak Boguslaw, Kadny Józef, Bielecka-Grzela Stanislawa, Maleszka Romuald, Lubi?ski J |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jul 08, 2020
- Content source: